Apr. 2, 2025 — Differences in the distribution of certain proteins and markers in the brain may explain why some people first experience vision changes instead of memory loss in Alzheimer's ...

Your loved one's treatments will depend on the type they have. Many older people fear that they have Alzheimer's disease because they can't find their eyeglasses or remember someone's name.

Randall Bateman, MD, Charles F and Joanne Knight Distinguished Professor of Neurology at WashU Medicine. A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to ...

Not spending enough time in the two deep stages of sleep — slow-wave and rapid eye movement, or REM, sleep — may hasten the deterioration of parts of the brain associated with Alzheimer’s ...

The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China, and Japan gave a green light to ...

These medications can slow disease progression, but are only effective in people during early stages of Alzheimer's. Prof Tara Spires-Jones, a neurodegeneration expert at the University of Edinburgh ...

Susan Aaron was an active 74-year-old retiree with Alzheimer’s who was told she might experience extreme fatigue and terrible headaches if she tried a new drug from Eisai Co. that promised to ...

Do you know a conference you think we should list? Let us know by sending us an email with the details to [email protected].

Current biomarkers of cognitive impairment in individuals with Alzheimer’s disease perform poorly. Now, a stronger predictor emerges.